ATC code J02
ATC code J02 Antimycotics for systemic use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup J02 is part of the anatomical group J Antiinfectives for systemic use.[1]
| ATC codes |
|---|
| J Antiinfectives for systemic use |
| J01 Antibacterials for systemic use |
| J02 Antimycotics for systemic use |
| J04 Antimycobacterials |
| J05 Antivirals for systemic use |
| Human only |
| J06 Immune sera and immunoglobulins |
| J07 Vaccines |
| ATCvet only |
| QJ51 Antibacterials for intramammary use |
| QJ54 Antimycobacterials for intramammary use |
|
|
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QJ02.[2] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
J02A Antimycotics for systemic use
J02AA Antibiotics
- J02AA01 Amphotericin B
- J02AA02 Hachimycin
J02AB Imidazole derivatives
- J02AB01 Miconazole
- J02AB02 Ketoconazole
- QJ02AB90 Clotrimazole
J02AC Triazole derivatives
- J02AC01 Fluconazole
- J02AC02 Itraconazole
- J02AC03 Voriconazole
- J02AC04 Posaconazole
- J02AC05 Isavuconazole
J02AX Other antimycotics for systemic use
- J02AX01 Flucytosine
- J02AX04 Caspofungin
- J02AX05 Micafungin
- J02AX06 Anidulafungin
References
- "ATC/DDD Index 2019: code J02". WHO Collaborating Centre for Drug Statistics Methodology.
- "ATCvet Index 2019: code QJ02". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.